296 related articles for article (PubMed ID: 18356622)
1. The use of botulinum toxin for spasticity after spinal cord injury.
Marciniak C; Rader L; Gagnon C
Am J Phys Med Rehabil; 2008 Apr; 87(4):312-7; quiz 318-20, 329. PubMed ID: 18356622
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
[TBL] [Abstract][Full Text] [Related]
5. Treatment of spasticity in spinal cord injury with botulinum toxin.
Palazón-García R; Alcobendas-Maestro M; Esclarin-de Ruz A; Benavente-Valdepeñas AM
J Spinal Cord Med; 2019 May; 42(3):281-287. PubMed ID: 29869974
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
7. Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors.
Franceschini M; Iocco M; Molteni F; Santamato A; Smania N;
Eur J Phys Rehabil Med; 2014 Oct; 50(5):525-33. PubMed ID: 24963604
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A for refractory post-stroke shoulder pain.
Pedreira G; Cardoso E; Melo A
Arq Neuropsiquiatr; 2008 Jun; 66(2A):213-5. PubMed ID: 18545785
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
10. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
Lagalla G; Danni M; Reiter F; Ceravolo MG; Provinciali L
Am J Phys Med Rehabil; 2000; 79(4):377-84; quiz 391-4. PubMed ID: 10892624
[TBL] [Abstract][Full Text] [Related]
11. Measuring spasticity and fine motor control (pinch) change in the hand after botulinum toxin-A injection using dynamic computerized hand dynamometry.
Barden HL; Baguley IJ; Nott MT; Chapparo C
Arch Phys Med Rehabil; 2014 Dec; 95(12):2402-9. PubMed ID: 24909588
[TBL] [Abstract][Full Text] [Related]
12. Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.
Mathevon L; Bonan I; Barnais JL; Boyer F; Dinomais M
Ann Phys Rehabil Med; 2019 Jul; 62(4):283-290. PubMed ID: 30063979
[TBL] [Abstract][Full Text] [Related]
13. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
[TBL] [Abstract][Full Text] [Related]
14. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
Sobolewski P
Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
16. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?
Al-Khodairy AT; Gobelet C; Rossier AB
Spinal Cord; 1998 Dec; 36(12):854-8. PubMed ID: 9881735
[TBL] [Abstract][Full Text] [Related]
17. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
18. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
19. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
[TBL] [Abstract][Full Text] [Related]
20. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
